image
Healthcare - Medical - Devices - NASDAQ - US
$ 22.93
1.06 %
$ 555 M
Market Cap
-18.64
P/E
1. INTRINSIC VALUE

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers.[ Read More ]

The intrinsic value of one KIDS stock under the base case scenario is HIDDEN Compared to the current market price of 22.9 USD, OrthoPediatrics Corp. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart KIDS

image
FINANCIALS
149 M REVENUE
21.62%
-25.8 M OPERATING INCOME
-18.25%
-21 M NET INCOME
-1667.25%
-27 M OPERATING CASH FLOW
-24.26%
41.7 M INVESTING CASH FLOW
136.76%
7.3 M FINANCING CASH FLOW
-94.63%
54.6 M REVENUE
3.35%
-5.57 M OPERATING INCOME
1.76%
-7.92 M NET INCOME
-31.35%
-9.94 M OPERATING CASH FLOW
-54.41%
-26.8 M INVESTING CASH FLOW
-135.90%
58.2 M FINANCING CASH FLOW
1581.79%
Balance Sheet Decomposition OrthoPediatrics Corp.
image
Current Assets 226 M
Cash & Short-Term Investments 80.3 M
Receivables 34.6 M
Other Current Assets 112 M
Non-Current Assets 212 M
Long-Term Investments 0
PP&E 41 M
Other Non-Current Assets 171 M
Current Liabilities 41.7 M
Accounts Payable 12.6 M
Short-Term Debt 152 K
Other Current Liabilities 28.9 M
Non-Current Liabilities 20.1 M
Long-Term Debt 9.91 M
Other Non-Current Liabilities 10.1 M
EFFICIENCY
Earnings Waterfall OrthoPediatrics Corp.
image
Revenue 149 M
Cost Of Revenue 37.5 M
Gross Profit 111 M
Operating Expenses 137 M
Operating Income -25.8 M
Other Expenses -4.79 M
Net Income -21 M
RATIOS
74.80% GROSS MARGIN
74.80%
-17.32% OPERATING MARGIN
-17.32%
-14.10% NET MARGIN
-14.10%
-5.56% ROE
-5.56%
-4.78% ROA
-4.78%
-6.55% ROIC
-6.55%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis OrthoPediatrics Corp.
image
Net Income -21 M
Depreciation & Amortization 17.4 M
Capital Expenditures -19 M
Stock-Based Compensation 10.5 M
Change in Working Capital -32.2 M
Others 1.69 M
Free Cash Flow -46 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets OrthoPediatrics Corp.
image
Wall Street analysts predict an average 1-year price target for KIDS of $38.1 , with forecasts ranging from a low of $28 to a high of $44 .
KIDS Lowest Price Target Wall Street Target
28 USD 22.11%
KIDS Average Price Target Wall Street Target
38.1 USD 66.34%
KIDS Highest Price Target Wall Street Target
44 USD 91.89%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership OrthoPediatrics Corp.
image
Sold
0-3 MONTHS
293 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
477 K USD 6
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Aug 21, 2024
Sell 293 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 10000
29.3 USD
8 months ago
Mar 11, 2024
Sell 88.6 K USD
Bailey David R
President and CEO
- 3213
27.59 USD
8 months ago
Mar 11, 2024
Sell 75.6 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 2741
27.59 USD
8 months ago
Mar 11, 2024
Sell 76.4 K USD
Odle Gregory A
President of Scoliosis
- 2768
27.59 USD
8 months ago
Mar 11, 2024
Sell 67.1 K USD
Throdahl Mark C
Director
- 2433
27.59 USD
8 months ago
Mar 11, 2024
Sell 88.2 K USD
Hite Fred
COO and CFO
- 3195
27.59 USD
8 months ago
Feb 22, 2024
Sell 81.5 K USD
Hauser Joseph W
Pres. Trauma & Def. Correction
- 2903
28.06 USD
1 year ago
Aug 11, 2023
Sell 99.8 K USD
Schlotterback Terry D
Director
- 2610
38.25 USD
1 year ago
Jun 26, 2023
Sell 190 K USD
Hite Fred
COO and CFO
- 4356
43.6877 USD
1 year ago
Apr 27, 2023
Sell 167 K USD
Odle Gregory A
President of Scoliosis
- 3333
50.0958 USD
1 year ago
Apr 25, 2023
Sell 41.4 K USD
Odle Gregory A
President of Scoliosis
- 828
50.0237 USD
1 year ago
Apr 21, 2023
Sell 32.2 K USD
Odle Gregory A
President of Scoliosis
- 644
50.0185 USD
1 year ago
Mar 06, 2023
Sell 180 K USD
Bailey David R
President and CEO
- 4052
44.4004 USD
1 year ago
Mar 06, 2023
Sell 179 K USD
Hite Fred
COO and CFO
- 4099
43.766 USD
1 year ago
Mar 06, 2023
Sell 151 K USD
Odle Gregory A
Executive Vice President
- 3421
44.0276 USD
1 year ago
Mar 06, 2023
Sell 198 K USD
Throdahl Mark C
Director
- 4515
43.8254 USD
1 year ago
Mar 06, 2023
Sell 148 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 3315
44.6203 USD
1 year ago
Mar 02, 2023
Sell 112 K USD
Hauser Joseph W
Sr VP & GM Trauma & Deformity
- 2554
43.7372 USD
1 year ago
Feb 02, 2023
Sell 59.8 K USD
Odle Gregory A
Executive Vice President
- 1195
50.003 USD
1 year ago
Jan 20, 2023
Sell 3.76 K USD
Odle Gregory A
Executive Vice President
- 80
47 USD
1 year ago
Jan 13, 2023
Sell 79.7 K USD
Odle Gregory A
Executive Vice President
- 1771
45 USD
1 year ago
Jan 09, 2023
Sell 10.3 K USD
Odle Gregory A
Executive Vice President
- 229
45.0437 USD
2 years ago
Aug 11, 2022
Bought 83.9 M USD
Squadron Capital Holdings LLC
director:
+ 1525000
54.9998 USD
2 years ago
Aug 11, 2022
Bought 457 USD
Squadron Capital LLC
10 percent owner
+ 1525000
0.0003 USD
2 years ago
Aug 11, 2022
Bought 83.9 M USD
Pelizzon David R
director:
+ 1525000
54.9998 USD
2 years ago
Aug 11, 2022
Bought 457 USD
Pelizzon David R
director, 10 percent owner:
+ 1525000
0.0003 USD
2 years ago
Aug 11, 2022
Bought 83.9 M USD
Pritzker Jennifer N.
director:
+ 1525000
54.9998 USD
2 years ago
Jun 16, 2022
Bought 48.7 K USD
Ruf Harold
director:
+ 1235
39.45 USD
2 years ago
Feb 07, 2022
Sell 148 K USD
Hauser Joseph W
Sr VP & GM Trauma & Deformity
- 3220
46.04 USD
2 years ago
Mar 02, 2022
Sell 236 K USD
Odle Gregory A
Executive Vice President
- 4108
57.55 USD
2 years ago
Mar 02, 2022
Sell 349 K USD
Throdahl Mark C
director:
- 5961
58.6 USD
2 years ago
Mar 02, 2022
Sell 283 K USD
Hite Fred
COO and CFO
- 4919
57.48 USD
2 years ago
Mar 02, 2022
Sell 229 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 3918
58.46 USD
2 years ago
Mar 02, 2022
Sell 237 K USD
Bailey David R
President and CEO
- 4078
58.1 USD
2 years ago
Dec 09, 2021
Bought 60.4 K USD
Pritzker Jennifer N.
10 percent owner
+ 1000
60.42 USD
2 years ago
Dec 09, 2021
Bought 30.1 K USD
Pritzker Jennifer N.
10 percent owner
+ 500
60.24 USD
2 years ago
Dec 09, 2021
Bought 30.2 K USD
Pritzker Jennifer N.
10 percent owner
+ 500
60.36 USD
2 years ago
Dec 10, 2021
Bought 29.1 K USD
Pritzker Jennifer N.
10 percent owner
+ 500
58.26 USD
3 years ago
Nov 11, 2021
Bought 54.8 K USD
Pelizzon David R
Director
+ 825
66.48 USD
3 years ago
Sep 07, 2021
Sell 24.8 K USD
Infante (Reynolds) Marie C
Director
- 359
69.185 USD
3 years ago
Sep 02, 2021
Sell 358 K USD
Hite Fred
COO and CFO
- 5000
71.5 USD
3 years ago
Aug 27, 2021
Bought 25.8 K USD
Pritzker Jennifer N.
10 percent owner
+ 400
64.55 USD
3 years ago
Aug 27, 2021
Bought 19.5 K USD
Pritzker Jennifer N.
10 percent owner
+ 300
64.84 USD
3 years ago
Aug 27, 2021
Bought 13.4 K USD
Pritzker Jennifer N.
10 percent owner
+ 207
64.87 USD
3 years ago
Aug 31, 2021
Sell 165 K USD
Burns Stephen F
Director
- 2445
67.58 USD
3 years ago
Aug 27, 2021
Sell 65.1 K USD
Burns Stephen F
Director
- 1000
65.14 USD
3 years ago
Aug 24, 2021
Sell 27.1 K USD
Burns Stephen F
Director
- 417
65 USD
3 years ago
Aug 09, 2021
Sell 7.2 K USD
Berry Bernie B III
Director
- 100
72 USD
3 years ago
Aug 03, 2021
Sell 312 K USD
Throdahl Mark C
Director
- 4774
65.4 USD
3 years ago
Aug 02, 2021
Sell 133 K USD
Berry Bernie B III
Director
- 2000
66.6 USD
3 years ago
Aug 02, 2021
Sell 1 M USD
Throdahl Mark C
Director
- 15226
65.88 USD
3 years ago
Jun 15, 2021
Sell 19.4 K USD
Berry Bernie B III
Director
- 300
64.54 USD
3 years ago
May 13, 2021
Bought 86.2 K USD
Pritzker Jennifer N.
10 percent owner
+ 1500
57.49 USD
3 years ago
May 13, 2021
Bought 27.9 K USD
Pritzker Jennifer N.
10 percent owner
+ 500
55.89 USD
3 years ago
May 13, 2021
Bought 28.1 K USD
Pritzker Jennifer N.
10 percent owner
+ 500
56.13 USD
3 years ago
May 13, 2021
Bought 28.1 K USD
Pritzker Jennifer N.
10 percent owner
+ 500
56.14 USD
3 years ago
May 10, 2021
Sell 252 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 4000
63.03 USD
3 years ago
May 10, 2021
Sell 296 K USD
Schlotterback Terry D
Director
- 4700
63.03 USD
3 years ago
May 06, 2021
Sell 193 K USD
Berry Bernie B III
Director
- 3209
60 USD
3 years ago
May 03, 2021
Sell 226 K USD
Odle Gregory A
Executive Vice President
- 3750
60.2 USD
3 years ago
May 03, 2021
Sell 288 K USD
Berry Bernie B III
Director
- 4791
60.15 USD
2 years ago
Dec 04, 2021
Bought 12.7 K USD
Pritzker Jennifer N.
10 percent owner
+ 300
42.33 USD
2 years ago
Dec 03, 2021
Bought 11.7 K USD
Pritzker Jennifer N.
10 percent owner
+ 300
38.98 USD
3 years ago
Nov 16, 2021
Bought 38.6 K USD
Pritzker Jennifer N.
10 percent owner
+ 800
48.31 USD
3 years ago
Mar 15, 2021
Bought 172 K USD
Pelizzon David R
Director
+ 3700
46.5 USD
3 years ago
Mar 15, 2021
Bought 135 K USD
Ruf Harold
Director
+ 2880
46.98 USD
3 years ago
Mar 16, 2021
Sell 32 K USD
Infante (Reynolds) Marie C
Director
- 700
45.78 USD
3 years ago
Mar 01, 2021
Sell 147 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 2633
55.85 USD
3 years ago
Mar 01, 2021
Sell 241 K USD
Hite Fred
COO and CFO
- 4310
55.87 USD
3 years ago
Mar 01, 2021
Sell 458 K USD
Odle Gregory A
Executive Vice President
- 8193
55.88 USD
3 years ago
Mar 01, 2021
Sell 285 K USD
Throdahl Mark C
CEO
- 5097
55.88 USD
3 years ago
Mar 01, 2021
Sell 266 K USD
Bailey David R
President
- 4769
55.84 USD
3 years ago
Feb 25, 2021
Sell 39.8 K USD
Berry Bernie B III
Director
- 699
57 USD
3 years ago
Feb 22, 2021
Sell 91.3 K USD
Berry Bernie B III
Director
- 1600
57.09 USD
3 years ago
Feb 19, 2021
Sell 212 K USD
Odle Gregory A
Executive Vice President
- 3750
56.5 USD
3 years ago
Feb 19, 2021
Sell 97.2 K USD
Berry Bernie B III
Director
- 1701
57.16 USD
3 years ago
Feb 18, 2021
Sell 216 K USD
Berry Bernie B III
Director
- 4000
54.07 USD
3 years ago
Feb 05, 2021
Sell 637 K USD
Throdahl Mark C
President and CEO
- 12651
50.34 USD
3 years ago
Feb 04, 2021
Sell 369 K USD
Throdahl Mark C
President and CEO
- 7349
50.18 USD
3 years ago
Jan 27, 2021
Sell 194 K USD
Odle Gregory A
Executive Vice President
- 3750
51.63 USD
3 years ago
Jan 27, 2021
Sell 162 K USD
Berry Bernie B III
Director
- 3136
51.73 USD
3 years ago
Dec 23, 2020
Sell 173 K USD
Odle Gregory A
Executive Vice President
- 3750
46.19 USD
4 years ago
Nov 10, 2020
Sell 376 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 8000
47.04 USD
4 years ago
Nov 10, 2020
Sell 345 K USD
Burns Stephen F
Director
- 7000
49.29 USD
4 years ago
Nov 09, 2020
Sell 141 K USD
Burns Stephen F
Director
- 3000
47.13 USD
4 years ago
Nov 09, 2020
Sell 240 K USD
Burns Stephen F
Director
- 5000
48.1 USD
4 years ago
Jun 25, 2020
Sell 574 K USD
Throdahl Mark C
President and CEO
- 13389
42.88 USD
4 years ago
May 27, 2020
Sell 308 K USD
Schlotterback Terry D
Director
- 6989
44 USD
4 years ago
May 27, 2020
Sell 507 USD
Schlotterback Terry D
Director
- 11
46.1 USD
4 years ago
May 28, 2020
Sell 46.8 K USD
Berry Bernie B III
Director
- 1000
46.75 USD
4 years ago
May 26, 2020
Sell 60 K USD
Berry Bernie B III
Director
- 1263
47.5 USD
4 years ago
May 26, 2020
Sell 93.8 K USD
Burns Stephen F
Director
- 2000
46.9 USD
4 years ago
May 26, 2020
Sell 139 K USD
Burns Stephen F
Director
- 3000
46.36 USD
4 years ago
May 21, 2020
Sell 45.7 K USD
Berry Bernie B III
Director
- 1000
45.71 USD
4 years ago
May 21, 2020
Sell 46 K USD
Burns Stephen F
Director
- 1000
46.05 USD
4 years ago
May 21, 2020
Sell 46.5 K USD
Burns Stephen F
Director
- 1000
46.48 USD
4 years ago
May 22, 2020
Sell 46.6 K USD
Burns Stephen F
Director
- 1000
46.57 USD
4 years ago
May 22, 2020
Sell 46.2 K USD
Burns Stephen F
Director
- 1000
46.23 USD
4 years ago
May 22, 2020
Sell 46.2 K USD
Burns Stephen F
Director
- 1000
46.2 USD
4 years ago
May 21, 2020
Sell 369 K USD
Odle Gregory A
Executive Vice President
- 8040
45.9 USD
4 years ago
May 21, 2020
Sell 18.6 K USD
Odle Gregory A
Executive Vice President
- 402
46.33 USD
4 years ago
May 20, 2020
Sell 224 K USD
Bailey David R
Executive Vice President
- 4824
46.51 USD
4 years ago
May 20, 2020
Sell 18.8 K USD
Bailey David R
Executive Vice President
- 402
46.77 USD
4 years ago
May 20, 2020
Sell 18.7 K USD
Bailey David R
Executive Vice President
- 402
46.6 USD
4 years ago
May 20, 2020
Sell 18.8 K USD
Bailey David R
Executive Vice President
- 402
46.74 USD
4 years ago
May 20, 2020
Sell 18.7 K USD
Bailey David R
Executive Vice President
- 402
46.57 USD
4 years ago
May 20, 2020
Sell 31.2 K USD
Throdahl Mark C
President and CEO
- 670
46.56 USD
4 years ago
May 20, 2020
Sell 18.7 K USD
Throdahl Mark C
President and CEO
- 402
46.56 USD
4 years ago
May 20, 2020
Sell 18.7 K USD
Throdahl Mark C
President and CEO
- 402
46.56 USD
4 years ago
May 20, 2020
Sell 18.7 K USD
Throdahl Mark C
President and CEO
- 402
46.57 USD
4 years ago
Dec 13, 2019
Sell 515 K USD
Bailey David R
Executive Vice President
- 15000
34.31 USD
4 years ago
Dec 13, 2019
Sell 343 K USD
Throdahl Mark C
President and CEO
- 10000
34.31 USD
4 years ago
Dec 13, 2019
Sell 515 K USD
Odle Gregory A
Executive Vice President
- 15000
34.31 USD
4 years ago
Dec 13, 2019
Sell 343 K USD
Hite Fred
Chief Financial Officer
- 10000
34.31 USD
6 years ago
Sep 13, 2018
Sell 33.2 K USD
Unger Kevin
Director
- 1000
33.22 USD
6 years ago
Sep 05, 2018
Sell 244 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 7247
33.73 USD
6 years ago
Sep 05, 2018
Sell 76.8 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 2278
33.72 USD
6 years ago
May 22, 2018
Bought 39 K USD
Pelizzon David R
Director
+ 2000
19.5 USD
6 years ago
Apr 13, 2018
Sell 494 K USD
Throdahl Mark C
President and CEO
- 27549
17.92 USD
6 years ago
Apr 13, 2018
Sell 528 K USD
Hite Fred
Chief Financial Officer
- 29471
17.92 USD
6 years ago
Apr 13, 2018
Sell 200 K USD
Gerritzen Daniel J
General Counsel and Secretary
- 11145
17.92 USD
6 years ago
Apr 13, 2018
Sell 594 K USD
Odle Gregory A
Executive Vice President
- 33161
17.92 USD
6 years ago
Apr 13, 2018
Sell 542 K USD
Bailey David R
Executive Vice President
- 30231
17.92 USD
6 years ago
Mar 12, 2018
Bought 67.7 K USD
Berry Bernie B III
Director
+ 3747
18.07 USD
6 years ago
Mar 12, 2018
Bought 17.5 K USD
Pelizzon David R
Director
+ 1000
17.5 USD
7 years ago
Oct 16, 2017
Bought 130 K USD
Pelizzon David R
Director
+ 10000
13 USD
7 years ago
Oct 16, 2017
Bought 150 K USD
Ruf Harold
Director
+ 11500
13 USD
16 years ago
Jan 18, 2008
Bought 2.81 B USD
TEXTOR JOHN C
Director
+ 25000
112500 USD
16 years ago
Jan 18, 2008
Bought 16.3 K USD
TEXTOR JOHN C
Director
+ 2550
6.4 USD
16 years ago
Jan 18, 2008
Bought 20 K USD
TEXTOR JOHN C
Director
+ 2538
7.88 USD
16 years ago
Jan 18, 2008
Bought 50.6 K USD
TEXTOR JOHN C
Director
+ 10300
4.913 USD
16 years ago
Jan 18, 2008
Bought 36.2 K USD
TEXTOR JOHN C
Director
+ 7696
4.701 USD
16 years ago
Jan 15, 2008
Bought 7.88 K USD
TEXTOR JOHN C
Director
+ 1300
6.062 USD
16 years ago
Jan 14, 2008
Bought 4.59 K USD
TEXTOR JOHN C
Director
+ 750
6.126 USD
16 years ago
Jan 11, 2008
Bought 5.97 K USD
TEXTOR JOHN C
Director
+ 950
6.289 USD
16 years ago
Jan 10, 2008
Bought 6.18 K USD
TEXTOR JOHN C
Director
+ 1000
6.175 USD
16 years ago
Jan 09, 2008
Bought 6.1 K USD
TEXTOR JOHN C
Director
+ 1000
6.105 USD
16 years ago
Jan 08, 2008
Bought 6 K USD
TEXTOR JOHN C
Director
+ 1000
5.999 USD
16 years ago
Jan 03, 2008
Bought 32.1 K USD
TEXTOR JOHN C
Director
+ 5914
5.42 USD
16 years ago
Jan 02, 2008
Bought 12 K USD
TEXTOR JOHN C
Director
+ 2000
6 USD
16 years ago
Jan 02, 2008
Bought 16.1 K USD
TEXTOR JOHN C
Director
+ 2500
6.43 USD
16 years ago
Dec 31, 2007
Bought 41.2 K USD
TEXTOR JOHN C
Director
+ 7000
5.88 USD
16 years ago
Dec 31, 2007
Bought 27.9 K USD
TEXTOR JOHN C
Director
+ 5000
5.572 USD
16 years ago
Dec 31, 2007
Bought 13.8 K USD
TEXTOR JOHN C
Director
+ 2500
5.5 USD
16 years ago
Dec 28, 2007
Bought 13.4 K USD
TEXTOR JOHN C
Director
+ 2500
5.341 USD
16 years ago
Dec 28, 2007
Bought 29.7 K USD
TEXTOR JOHN C
Director
+ 5000
5.938 USD
16 years ago
Dec 27, 2007
Bought 29.6 K USD
TEXTOR JOHN C
Director
+ 5000
5.926 USD
16 years ago
Dec 20, 2007
Bought 29.7 K USD
TEXTOR JOHN C
Director
+ 5100
5.821 USD
16 years ago
Dec 19, 2007
Bought 146 K USD
TEXTOR JOHN C
Director
+ 25000
5.8462 USD
7. News
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer Fred Hite - Chief Financial Officer & Chief Operating Officer Conference Call Participants Matt O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Good morning and welcome to OrthoPediatrics Corporation's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com - 1 week ago
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 week ago
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates OrthoPediatrics (KIDS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.13 per share a year ago. zacks.com - 1 week ago
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance WARSAW, Ind., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2024. globenewswire.com - 1 week ago
KAMALA HARRIS NAMED WINNER OF NICKELODEON'S KIDS PICK THE PRESIDENT "KIDS' VOTE" POLL BRAND-NEW KIDS PICK THE PRESIDENT SPECIAL, HOSTED BY NATE BURLESON AND HIS DAUGHTER MIA, DEBUTS TONIGHT AT 8 P.M. (ET/PT) ON NICKELODEON PLATFORMS AND PARAMOUNT+ Share it: @Nickelodeon #KidsPickthePresident Click HERE  to download assets. prnewswire.com - 2 weeks ago
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024 WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2024 financial results on Wednesday, November 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, November 7, 2024, at 8:00 a.m. ET to discuss the results. globenewswire.com - 3 weeks ago
What Makes OrthoPediatrics (KIDS) a New Strong Buy Stock OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 1 month ago
POTTERY BARN, POTTERY BARN KIDS AND POTTERY BARN TEEN LAUNCH COLLABORATIONS WITH HUSBAND-AND-WIFE DUO, CHRIS LOVES JULIA SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn, Pottery Barn Kids and Pottery Barn Teen, portfolio brands of Williams-Sonoma, Inc. (NYSE: WSM), the world's largest digital-first, design-led and sustainable home retailer, announced today, new home furnishings collections with Chris and Julia Marcum, of the popular design blog, Chris Loves Julia. Predicated on the success of the Chris Loves Julia collaboration for Pottery Barn Kids that launched in 2023, the design duo has expanded their collaborat. businesswire.com - 1 month ago
Down -15.65% in 4 Weeks, Here's Why You Should You Buy the Dip in OrthoPediatrics (KIDS) OrthoPediatrics (KIDS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com - 1 month ago
NICKELODEON LETS KIDS' VOICES BE HEARD THIS ELECTION SEASON WITH RETURN OF KIDS PICK THE PRESIDENT "KIDS' VOTE" POLL AND BRAND-NEW SPECIAL NICK'S "KIDS' VOTE" LAUNCHES TODAY, WITH RESULTS REVEALED IN SPECIAL HOSTED BY NATE BURLESON AND HIS DAUGHTER MIA, DEBUTING MONDAY, OCT. 28, ON NICKELODEON PLATFORMS AND PARAMOUNT+ Share it: @Nickelodeon #KidsPickthePresident Click HERE  to download asset. prnewswire.com - 1 month ago
Bears are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now OrthoPediatrics (KIDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. zacks.com - 1 month ago
Does OrthoPediatrics (KIDS) Have the Potential to Rally 36.3% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 36.3% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com - 1 month ago
8. Profile Summary

OrthoPediatrics Corp. KIDS

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 555 M
Dividend Yield 0.00%
Description OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Contact 2850 Frontier Drive, Warsaw, IN, 46582 https://www.orthopediatrics.com
IPO Date Oct. 13, 2017
Employees 247
Officers Mr. Mark Karshner Senior Vice President of International Sales Mr. Joseph W. Hauser President of Trauma & Deformity Correction Mr. Fred L. Hite Chief Financial Officer, Principal Financial & Accounting Officer, Chief Operating Officer and Director Mr. David R. Bailey President, Chief Executive Officer & Director Mr. Gregory A. Odle President of Scoliosis Mr. Mark C. Throdahl Executive Chairman Mr. Kevin L. Unger CHE, MBA/MSHA President of Enabling Technologies Mr. Joel Batts Senior Vice President of Clinical & Regulatory Affairs